Literature DB >> 8904004

Isoproterenol infusion provokes vasovagal response without upright tilt in a patient exhibiting syncopal episodes.

M Shihara1, Y Harasawa, S Ando, M Mohri, A Takeshita.   

Abstract

We report a case of a patient with vasovagal syncope, in whom isoproterenol infusion provoked vasovagal response without upright tilting. We subjected the patient, who had had two previous syncopal and several presyncopal episodes, to upright tilting with isoproterenol infusion. Before a control tilt was performed for 10 min (80 degrees), the patient was placed in the supine position for 5 min. The control tilt did not provoke a vasovagal response. With isoproterenol being infused at a dose of 1 mu g/min, the sequence of positioning in the supine position for 5 min and upright tilting for 10 min was repeated. This dose of isoproterenol infusion did not provoke any vasovagal response in the patient, either in the supine or in the upright position. When the dose of isoproterenol infusion was then increased to 2 mu g/min, the heart rate increased to 121/min, but then suddenly dropped to 74/min; systemic arterial pressure simultaneously fell from 148/80 to 108/80 mmHg. The patient complained of palpitation and anxiety, and showed profound cold sweating. The drop in the heart rate and the fall in blood pressure occurred when the patient was in the supine position, indicating that, unlike upright tilting with isoproterenol infusion, venous return was not decreased at the beginning of vasovagal response in this setting. This observation suggests that isoproterenol infusion, even without upright tilting, may provoke the vasovagal response in some patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8904004     DOI: 10.1007/bf01744908

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  11 in total

1.  Reproducibility of head upright tilt table test results in patients with syncope.

Authors:  B P Grubb; D Wolfe; P Temesy-Armos; H Hahn; L Elliott
Journal:  Pacing Clin Electrophysiol       Date:  1992-10       Impact factor: 1.976

2.  Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons.

Authors:  M B Waxman; L Yao; D A Cameron; R W Wald; J Roseman
Journal:  Am J Cardiol       Date:  1989-01-01       Impact factor: 2.778

3.  Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope.

Authors:  A Almquist; I F Goldenberg; S Milstein; M Y Chen; X C Chen; R Hansen; C C Gornick; D G Benditt
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

4.  Ventricular syncope: is the heart a sensory organ?

Authors:  F M Abboud
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

5.  Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.

Authors:  B P Grubb; P Temesy-Armos; H Hahn; L Elliott
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

Review 6.  Psychologic stress, vasodepressor (vasovagal) syncope, and sudden death.

Authors:  G L Engel
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

Review 7.  Upright tilt testing in evaluating syncope: a comprehensive literature review.

Authors:  W N Kapoor; M A Smith; N L Miller
Journal:  Am J Med       Date:  1994-07       Impact factor: 4.965

8.  The value of tilt table testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin.

Authors:  G E Tonnessen; J I Haft; J Fulton; D G Rubenstein
Journal:  Arch Intern Med       Date:  1994-07-25

9.  Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test.

Authors:  W N Kapoor; N Brant
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

10.  A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.

Authors:  C A Morillo; J W Leitch; R Yee; G J Klein
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.